Cerebrospinal fluid vasopressin and symptom severity in children with autism.
Where this comes from
- Record sourced from PubMed, PMID 30152888.
- Also identified by DOI 10.1002/ana.25314 and PMC identifier 6719782.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autism is a brain disorder characterized by social impairments. Progress in understanding autism has been hindered by difficulty in obtaining brain-relevant tissues (eg, cerebrospinal fluid [CSF]) by which to identify markers of disease and targets for treatment. Here, we overcome this barrier by providing evidence that mean CSF concentration of the "social" neuropeptide arginine vasopressin (AVP) is lower in children with autism versus controls. CSF AVP concentration also significantly differentiates individual cases from controls and is associated with greater social symptom severity in children with autism. These findings indicate that AVP may be a promising CSF marker of autism's social deficits. Ann Neurol 2018;84:611-615.
Medical subject headings
- Autistic Disorder
- Neurophysins
- Protein Precursors
- Severity of Illness Index
- Vasopressins